| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $191.2M | — | +57.4% |
| R&D Expense | $52.7M | — | +17.6% |
| SG&A Expense | $185.0M | — | +53.2% |
| Operating Income | -$63.4M | — | -11.2% |
| Interest Expense | $3.1M | — | +158.8% |
| Pre-tax Income | -$64.5M | — | -8.6% |
| Income Tax | $0 | — | — |
| Net Income | -$64.5M | — | -8.6% |
| EPS (Basic) | -$1.26 | — | -3.3% |
| EPS (Diluted) | -$1.26 | — | -3.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $305.1M | -5.5% | +1.4% |
| Accounts Receivable | $251.1M | +11.8% | +55.6% |
| Inventory | $31.5M | +12.8% | +93.1% |
| Current Assets | $611.2M | +3.8% | +23.6% |
| Total Assets | $713.6M | +3.5% | +19.6% |
| Current Liabilities | $439.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$20.7M | — | +52.3% |
| Capital Expenditures | $121K | — | -64.2% |
| Investing Cash Flow | -$121K | — | +64.2% |
| Financing Cash Flow | $3.0M | — | -89.8% |
| Free Cash Flow | -$20.8M | — | +52.4% |
| +80.1% |
| Long-term Debt | $117.8M | +0.1% | -35.0% |
| Total Liabilities | $659.0M | +9.6% | +21.3% |
| Stockholders' Equity | $54.6M | -38.2% | +2.6% |